References
- Cohen MS, Shaw GM, McMichael AJ, et al. Acute HIV-1 infection. N Engl J Med. 2011;364(20):1943–1954.
- Hladik F, McElrath MJ. Setting the stage: host invasion by HIV. Nat Rev Immunol. 2008;8(6):447–457.
- Lackner AA, Lederman MM, Rodriguez B. HIV pathogenesis: the host. Cold Spring Harb Perspect Med. 2012;2(9):a007005.
- HIV/AIDS basic statistics [Internet]. Atlanta (GA): Centers for Disease Control and Prevention; 2018; [updated 2018 Nov 19; cited 2018 Dec 11]. Available from: https://www.cdc.gov/hiv/basics/statistics.html
- Palella FJ Jr, Baker RK, Moorman AC, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006;43(1):27–34.
- HIV among people aged 50 and older [Internet]. Atlanta (GA): Centers for Disease Control and Prevention; 2018; [updated 2018 Sep 18; cited 2018 Dec 11]. Available from: https://www.cdc.gov/hiv/group/age/olderamericans/index.html
- Clinical guidelines [Internet]. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Rockville (MD): U.S. Department of Health and Human Services; 2018; [updated 2018 Oct 25; cited 2018 Dec 11]:[332 p.]. Available from: https://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf
- Bedimo R, Maalouf NM, Zhang S, et al. Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents. AIDS. 2012;26(7):825–831.
- Margolis AM, Heverling H, Pham PA, et al. A review of the toxicity of HIV medications. J Med Toxicol. 2014;10(1):26–39.
- Al-Dakkak I, Patel S, McCann E, et al. The impact of specific HIV treatment-related adverse events on adherence to antiretroviral therapy: a systematic review and meta-analysis. AIDS Care. 2013;25(4):400–414.
- Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection [Internet]. Clinical guidelines: managing common coinfections and comorbidities. Geneva, Switzerland: World Health Organization; 2016; [cited 2019 Nov 7]:[46 p.]. Available from: https://www.who.int/hiv/pub/arv/chapter5.pdf?ua=1
- Salter ML, Lau B, Go VF, et al. HIV infection, immune suppression, and uncontrolled viremia are associated with increased multimorbidity among aging injection drug users. Clin Infect Dis. 2011;53(12):1256–1264.
- Summary Health Statistics [Internet]. National Health Interview Survey; 2016. Atlanta (GA): Centers for Diseases Control and Prevention; 2018; [cited 2018 Dec 11]:[9 p.]. Available from: https://ftp.cdc.gov/pub/Health_Statistics/NCHS/NHIS/SHS/2016_SHS_Table_A-1.pdf
- Health, United States, 2017. Data finder [Internet]. Selected health conditions and risk factors, by age: United States, selected years 1988–1994 through 2015–2016; 2017. Atlanta (GA): Centers for Disease Control and Prevention; 2018; [cited 2018 Dec 11]:[2 p.]. Available from: https://www.cdc.gov/nchs/data/hus/2017/053.pdf
- Gallant J, Hsue PY, Shreay S, et al. Comorbidities among US patients with prevalent HIV infection-a trend analysis. J Infect Dis. 2017;216(12):1525–1533.
- Guaraldi G, Orlando G, Zona S, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis. 2011;53(11):1120–1126.
- Ryom L, Mocroft A, Kirk O, et al. Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study. J Infect Dis. 2013;207(9):1359–1369.
- Zhou S, Martin K, Corbett A, et al. Total daily pill burden in HIV-infected patients in the southern United States. AIDS Patient Care STDS. 2014;28(6):311–317.
- Gimeno-Gracia M, Crusells-Canales MJ, Armesto-Gomez FJ, et al. Polypharmacy in older adults with human immunodeficiency virus infection compared with the general population. Clin Interv Aging. 2016;11:1149–1157.
- Jakeman B, Nasiri M, Ruth L, et al. Comparing the frequencies of contraindicated drug–drug interactions between differing antiretroviral regimens in HIV-infected patients. Ann Pharmacother. 2017;51(5):365–372.
- Corado KC, Caplan MR, Daar ES. Two-drug regimens for treatment of naive HIV-1 infection and as maintenance therapy. Drug Des Devel Ther. 2018;12:3731–3740.
- Juluca [package insert]. Research Triangle Park (NC): ViiV Healthcare; 2017.
- Medicaid and HIV [Internet]. Medicaid and HIV fact sheet. San Francisco (CA): Kaiser Family Foundation; 2018; [updated 2016 Oct 24; cited 2018 Dec 11]:[6 p.]. Available from: http://files.kff.org/attachment/Fact-Sheet-Medicaid-and-HIV
- State health facts: Medicare [Internet]. San Francisco (CA): Kaiser Family Foundation; 2018. Dual eligibles’ share of Medicaid spending; 2013 FY [cited 2018 Dec 11]; [about 2 screens]. Available from: https://www.kff.org/medicaid/state-indicator/duals-share-of-medicaid-spending/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D